The family of a 27-year-old man who died from ketamine toxicity has filed a wrongful-death lawsuit against Orlando, Florida-based telehealth company Mindbloom, Inc., alleging the at-home ketamine program prioritized profits over patient safety.
The lawsuit, filed Tuesday in Pitt County Superior Court, North Carolina, claims that Mindbloom’s model of providing at-home ketamine—a Class III controlled substance—failed to adequately screen and monitor Phillip Ward of Greenville, who died on October 29, 2023.
Mindbloom, which markets itself as a provider of medically supervised at-home ketamine therapy for mental health disorders, claims on its website that none of its nearly 60,000 customers has ever overdosed…